Nivolumab in pretreated non-small cell lung cancer: Continuing the immunolution
01 Pubblicazione su rivista
Salati Massimiliano, Baldessari Cinzia, Cerbelli Bruna, Botticelli Andrea
ISSN: 2218-6751
Comment on
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057). [J Clin Oncol. 2017]